Cart contains    items

Browse by molecule: [A]  [B]  [C]  [D]  [E]  [F]  [G]  [H]  [I]  [J]  [K]  [L]  [M]  [N]  [O]  [P]  [Q]  [R]  [S]  [T]  [U]  [V]  [W]  [X]  [Y]  [Z]  

Human Urokinase-type plasminogen activator Recombinant


accession:  P00749
   Size A     10ug   $ 160
   Size B      50ug  $680
   Size C      200ug  $ 1950
Domain  :  peptidase,EGF,Kringles
Gene  :  PLAU
Catalog no. :  RKP00749



Optimized DNA sequence  encoding peptidase domain of Human uPA (SER21 - LEU431) including a C-terminal His tag was expressed in HEK293 cells.

Molecular weight:

Recombinant human Urokinase-type plasminogen activator (uPA) is a protein consisting of 420 amino acid residue subunits,due to glycosylation and cleavage migrates as an approximately 18kDa,32kDa,50kDa bands protein on reduced SDS-PAGE.

>95%, as determined by SDS-PAGE and HPLC
Biological activity:
The activity was tested by the ability of cleave the fluorogenic peptide substrate and was measured to be >2 nMoles/min/ug
Endotoxin content was assayed using a LAL gel clot method.
Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg).

Recombinant Human Furin is lyophilized  from 0.2 μm filtered PBS solution,  pH7.2 ,  5% Trehalose.

A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

Recombinant uPA can be stored in working aliquots at 2° - 8° C for one month, or at -20°C to -70°C for twelve months.

Avoid repeated freeze/thaw cycles.

This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.


Urokinase-type plasminogen activator

uPA is secreted as a 50-kDa single-chain proenzyme (scuPA) composed of three structurally identifiable domains: a growth factor- like domain (GFD; amino acids 146), which binds a specific receptor (uPAR/CD87) , a kringle domain , and a proteolytic domain , which includes a serine protease catalytic site. Plasmin and several other serine proteases cleave soluble or uPAR-bound scuPA to generate an enzymatically active, two- chain molecule (tcuPA) that is inhibited primarily by PAI-1 in plasma and in the lung

Related Publications:
serum soluble Urokinase-type plasminogen activator receptor levels and idiopathic fsgs in children: a single-center report
Clin. J. Am. Soc. Nephrol., Aug 2013; 8: 1304 - 1311.
keratinocytes and head and neck squamous cell carcinoma cells regulate Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in fibroblasts
Anticancer Res, Aug 2013; 33: 3113 - 3118.
inactivation of Urokinase-type plasminogen activator receptor (upar) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Ann Rheum Dis, Jul 2013; 10.1136/annrheumdis-2013-203706.
tgf-beta2 promotes rpe cell invasion into collagen gel by mediating Urokinase-type plasminogen activator (upa) expression
Invest. Ophthalmol. Vis. Sci., Jun 2013; 54: 2012.
subtoxic dosage of methylglyoxal stimulated production of Urokinase-type plasminogen activator by retinal pigment epithelial cells
Invest. Ophthalmol. Vis. Sci., Jun 2013; 54: 4601.

by class:
Growth factors
CD markers
Viral Antigens
by species:
Purified Polyclonal
Related Products:
product_icon_8.jpg Mouse uPAR Recombinant
product_icon_8.jpg Human uPAR Recombinant
product_icon_8.jpg Human Urokinase-type plasminogen activator Recombinant
Item name Size Quantity Price(USD) Remove
Cart Total $